Search

TransMedics Group Inc

Deschisă

SectorSănătate

93.49 1.47

Rezumat

Modificarea prețului

24h

Curent

Minim

91.07

Maxim

94.29

Indicatori cheie

By Trading Economics

Venit

7.4M

15M

Vânzări

16M

190M

P/E

Medie Sector

22.948

57.371

EPS

0.44

Marjă de profit

7.729

Angajați

898

EBITDA

-889K

27M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+0.66% upside

Dividende

By Acuity

Următoarele câștiguri

28 oct. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

245M

3.1B

Deschiderea anterioară

92.02

Închiderea anterioară

93.49

Sentimentul știrilor

By Acuity

100%

0%

326 / 340 Clasament în Healthcare

TransMedics Group Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 aug. 2026, 23:06 UTC

TransMedics Group Inc shares are lower in after-market hours, reflecting a decline since Monday's close. Broader market concerns about the U.S.-Iran conflict persist.

21 aug. 2026, 19:36 UTC

Transmedics Group Inc shares are higher, maintaining an upward trend since Thursday's close despite a pullback from earlier session highs. No specific news identified.

20 aug. 2026, 19:46 UTC

Transmedics Group Inc is trading lower today, following an early drop that set the day's low. No specific news was identified for the decline.

19 aug. 2026, 23:11 UTC

Transmedics Group Inc is trading lower in after-market hours, having retraced from a brief peak earlier in the session amid routine price activity.

18 aug. 2026, 19:16 UTC

Social Media

Transmedics Group plans to accelerate revenue growth, projecting $757 million by 2026. Shares are higher today, rebounding from earlier session lows.

13 aug. 2026, 19:52 UTC

Transmedics Group Inc shares are trading higher, recovering from an earlier low. The stock remains above its 20-day moving average amid strong sector interest.

12 aug. 2026, 19:36 UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

11 aug. 2026, 19:16 UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

10 aug. 2026, 19:21 UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

7 aug. 2026, 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

6 aug. 2026, 20:03 UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

5 aug. 2026, 20:03 UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

4 aug. 2026, 23:02 UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

3 aug. 2026, 19:51 UTC

Social Media
News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

30 iul. 2026, 19:03 UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

29 iul. 2026, 23:36 UTC

Transmedics Group Inc. shares are lower in after-market trading, reflecting broader market volatility amid rising interest rates and geopolitical tensions.

28 iul. 2026, 19:46 UTC

Transmedics Group Inc shares are higher today, advancing since Monday. The stock peaked earlier but pulled back from a session high.

27 iul. 2026, 15:16 UTC

Social Media
News

Transmedics Group Inc is higher today amid social media discussions on its undervaluation and expectations for significant profit by 2028.

24 iul. 2026, 20:02 UTC

Social Media

Transmedics Group Inc gains amid positive feedback from Jefferies on its technology and growth prospects, aligning with strength in the Health Care Equipment sector.

22 iul. 2026, 19:46 UTC

Transmedics Group Inc shares are lower today, reflecting ongoing declines. The stock's volatility coincides with rising crude oil prices amid geopolitical tensions.

21 iul. 2026, 14:36 UTC

Social Media

Transmedics Group's shares are higher today following the first lung transplant using its OCS warm-perfusion device, enhancing organ preservation and clinical outcomes.

20 iul. 2026, 12:26 UTC

Social Media

TransMedics Group Inc shares are higher in pre-market trading amid strong operational growth, with flights exceeding 36 per day and projected revenue of $3 billion by 2032.

Comparație

Modificare preț

TransMedics Group Inc Așteptări

Obiectiv de preț

By TipRanks

0.66% sus

Prognoză pe 12 luni

Medie 94.22 USD  0.66%

Maxim 122 USD

Minim 65 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTransMedics Group Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

11 ratings

7

Cumpărare

4

Păstrare

0

Vânzare

Sentiment

By Acuity

326 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat